Near-Patient Newborn and Pediatric Testing

Life-threatening conditions for newborns require multiple tests and large sample volumes for an accurate diagnosis. FINDER is a near-patient testing platform that operates on 50 microliters of blood.

FINDER currently tests for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.

Powered by digital microfluidics, FINDER is specifically designed to address the need for tests requiring low blood volume - with a turnaround time of approximately
15 minutes after sample introduction.

FINDER features:

  • Small sample size
  • Small footprint
  • Rapid time to result
  • Simple workflow
  • No sample preparation
  • Robust development pipeline

Related News

Baebies Wins the 2020 AACC Disruptive Technology Award

Submission of 510(k) to U.S. FDA for G6PD

CE Mark for FINDER, a Near-Patient Testing Platform for G6PD

Peer-reviewed Publications

A Novel Point-of-care Device for Measuring G6PD Enzyme Deficiency

Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric Patients

Baebies 2020 AACC Award Winner

FINDER Workflow

FINDER is an innovative platform that operates on 50 microliters of blood for testing. At just 8 inches wide and with a tablet for user interface, FINDER can be used in various settings. FINDER consumables are preloaded with all necessary reagents.

Baebies FINDER workflow

FINDER® is CE-marked and US FDA cleared.